Valuation: ConvaTec Group Plc

Market Cap 6.62B 5.98B 5.52B 5B 9.43B 622B 9.72B 66.3B 26.35B 333B 24.83B 24.31B 1,059B P/E 2026 *
26.3x
P/E 2027 * 17.8x
Enterprise Value 8.02B 7.26B 6.7B 6.06B 11.44B 754B 11.78B 80.4B 31.95B 403B 30.12B 29.47B 1,284B EV / Sales 2026 *
3.14x
EV / Sales 2027 * 2.87x
Free-Float
95.08%
Yield 2026 *
2.36%
Yield 2027 * 2.7%
1 day+0.59%
1 week+2.72%
Current month+5.24%
1 month+11.44%
3 months+10.96%
6 months+24.49%
Current year+5.76%
1 week 247.6
Extreme 247.6
258.6
1 month 230.6
Extreme 230.6
258.6
Current year 193
Extreme 193
259.3
1 year 193
Extreme 193
259.3
3 years 193
Extreme 193
311.2
5 years 165.3
Extreme 165.3
311.2
10 years 113.25
Extreme 113.25
349.1
Manager TitleAgeSince
Chief Executive Officer 62 2025-08-03
Director of Finance/CFO 51 2025-08-03
Chief Operating Officer - 2026-05-31
Director TitleAgeSince
Chairman 78 2019-09-29
Director/Board Member 62 2020-03-01
Director/Board Member 66 2020-06-30
Date Insider Type Main position Quantity % Market Cap. Importance
10/13/26 Buy

Director

24,400 0.0013%
5/26/26 Buy

Chief Executive Officer

50,000 0.0026%
5/26/26 Buy

Chief Financial Officer

24,993 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+0.55%+2.72%+3.46%+23.30% 6.62B
-1.87%-5.59%-16.74%+14.13% 186B
-0.61%-3.67%+5.41%+42.88% 124B
-2.01%-6.77%-14.96%+14.17% 119B
+0.64%-6.58%-43.40%+2.43% 91.43B
-0.14%+2.86%-3.86%+76.84% 66.67B
+0.55%+1.01%+12.28%-8.07% 58.76B
-0.65%+4.07%-2.18%+62.81% 54.99B
-0.68%+6.83%-1.64%+55.26% 49.93B
-5.17%+0.55% - - 35.13B
Average -0.93%-1.67%-6.85%+31.53% 79B
Weighted average by Cap. -1.05%-3.33%-10.45%+27.55%

Financials

2026 *2027 *
Net sales 2.55B 2.31B 2.13B 1.93B 3.64B 240B 3.75B 25.59B 10.17B 128B 9.58B 9.38B 409B 2.73B 2.47B 2.28B 2.06B 3.9B 257B 4.01B 27.38B 10.88B 137B 10.25B 10.04B 437B
Net income 248M 224M 207M 187M 353M 23.3B 364M 2.48B 987M 12.46B 930M 910M 39.65B 367M 332M 306M 277M 523M 34.49B 539M 3.68B 1.46B 18.44B 1.38B 1.35B 58.68B
Net Debt 1.41B 1.27B 1.17B 1.06B 2.01B 132B 2.07B 14.1B 5.6B 70.72B 5.28B 5.17B 225B 1.23B 1.11B 1.03B 928M 1.75B 115B 1.8B 12.31B 4.89B 61.74B 4.61B 4.51B 197B
Projected Income Statement - Annual - ConvaTec Group Plc
Logo ConvaTec Group Plc
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,000
Date Price Change Volume
26-11-13 GBX 256.60 +0.31% 415,747
26-11-12 GBX 255.80 +0.95% 12,909,992
26-11-11 GBX 253.40 +1.93% 4,606,452
26-11-10 GBX 248.60 0.00% 3,115,854
26-11-09 GBX 248.60 -0.72% 3,927,195
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - ConvaTec Group Plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
3.386USD
Average target price
4.021USD
Spread / Average Target
+18.78%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ConvaTec Group Plc
  1. Stock Market
  2. Stocks
  3. CTEC Stock